½ÉÇ÷°ü ÃÊÀ½ÆÄ ½ÃÀå ±Ô¸ð ¹× ¿¹Ãø, ¼¼°è ¹× Áö¿ªº° Á¡À¯À², µ¿Çâ, ¼ºÀå ±âȸ ºÐ¼® ¸®Æ÷Æ® : À¯Çüº°, ±â¼úº°, ÃÖÁ¾»ç¿ëÀÚº°, Áö¿ªº°
Cardiovascular Echocardiography Market Size and Forecasts, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type, Technology, End User, and Geography
»óǰÄÚµå
:
1471960
¸®¼Ä¡»ç
:
The Insight Partners
¹ßÇàÀÏ
:
2024³â 03¿ù
ÆäÀÌÁö Á¤º¸
:
¿µ¹® 150 Pages
¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
½ÉÇ÷°ü ÃÊÀ½ÆÄ ½ÃÀå ±Ô¸ð´Â 2022³â 1,437¾ï 2,000¸¸ ´Þ·¯¿¡¼ 2030³â¿¡´Â 2,000¾ï ´Þ·¯·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, 2022-2030³â CAGRÀº 4.2%·Î ¿¹ÃøµË´Ï´Ù.
½ÉÇ÷°ü ÃÊÀ½ÆÄ´Â À½ÆÄ¸¦ ÀÌ¿ëÇÏ¿© ½ÉÀåÀÇ ¿µ»óÀ» ¸¸µå´Â °Ë»çÀÔ´Ï´Ù. ÀÌ °Ë»ç´Â ÀϹÝÀûÀ¸·Î ½ÉÀå ÁúȯÀÌ Àǽɵǰųª ¾Ë·ÁÁø ȯÀÚ¿¡°Ô ½ÃÇàµË´Ï´Ù. ÀÌ °Ë»ç´Â ÅëÁõÀÌ ¾ø°í, ½ÉÀåÀÇ »óŸ¦ ÆÄ¾ÇÇÒ ¼ö ÀÖ½À´Ï´Ù. À̹ÌÁö´Â ½ÉÀåÀÇ Å©±â, ¸ð¾ç, ¹æ, ÆÇ¸·°ú ±× ±â´ÉÀ» º¸¿©ÁÝ´Ï´Ù. ½ÉÇ÷°ü ÃÊÀ½ÆÄ´Â ½ÉÀåÀÇ ¼öÃàÀÌ Á¦´ë·Î ÀÌ·ç¾îÁöÁö ¾Ê´Â ºÎÀ§¸¦ È®ÀÎÇÒ ¼öµµ ÀÖ½À´Ï´Ù. ½ÉÀå ÃÊÀ½ÆÄ °Ë»ç´Â ½ÉÀå ¹ßÀÛÀ¸·Î ÀÎÇÑ ºÎ»óÀ» ¸íÈ®ÇÏ°Ô ½Ã°¢È ÇÒ ¼ö ÀÖ½À´Ï´Ù. ½ÉÀå ÁúȯÀ» ¹ß°ßÇϱâ À§ÇØ ÀϹÝÀûÀ¸·Î »ç¿ëµÇ´Â Áø´Ü °Ë»ç´Â ºñħ½À¼ºÀ¸·Î ÀÎÇØ °æÈäºÎ ½ÉÀå ÃÊÀ½ÆÄ °Ë»çÀÔ´Ï´Ù. ½ÉÇ÷°ü ÃÊÀ½ÆÄ ½ÃÀåÀÇ ¼ºÀåÀº ½ÉÇ÷°ü ÁúȯÀÇ ºÎ´ãÀÌ Áõ°¡ÇÏ°í ´Ù¸¥ ½ÉÀå Áø´Ü ÀýÂ÷¿¡ ºñÇØ ½ÉÃÊÀ½ÆÄ Àåºñ°¡ ¿ì¼öÇÏ´Ù´Â Á¡À¸·Î ÀÎÇØ ¼ºÀåÇϰí ÀÖ½À´Ï´Ù. ±×·¯³ª ½ÉÃÊÀ½ÆÄ Àåºñ »ç¿ë¿¡ µû¸¥ ¹®Á¦Á¡ÀÌ ½ÉÇ÷°ü ÃÊÀ½ÆÄ ½ÃÀåÀÇ ¼ºÀåÀ» ÀúÇØÇϰí ÀÖ½À´Ï´Ù.
À¯Çüº° ÀλçÀÌÆ®
½ÉÇ÷°ü ÃÊÀ½ÆÄ ½ÃÀåÀº ±â¼úº°·Î 2D ½ÉÃÊÀ½ÆÄ, 3D ½ÉÃÊÀ½ÆÄ, µµÇ÷¯·Î ºÐ·ùµÇ¸ç, 3D ½ÉÃÊÀ½ÆÄ ºÐ¾ß´Â 2022³â ½ÉÇ÷°ü ÃÊÀ½ÆÄ ½ÃÀå¿¡¼ °¡Àå Å« Á¡À¯À²À» Â÷ÁöÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÌ ºÎ¹®Àº ¿¹Ãø ±â°£ Áß °¡Àå ³ôÀº CAGRÀ» ³ªÅ¸³¾ °ÍÀ¸·Î ¿¹»óµÇ¸ç, 3D ½ÉÃÊÀ½ÆÄ´Â ½ÉÀå ±¸Á¶ÀÇ 3Â÷¿ø À̹ÌÁö¸¦ ÃÔ¿µÇÏ¿© À̹ÌÁö ǰÁú°ú ÆÇµ¶±âÀÇ ½Å·Ú¼ºÀ» Çâ»ó½ÃŰ°í ±¸Á¶¿Í ±â´ÉÀ» Æò°¡ÇÏ´Â µ¥ »ç¿ëµË´Ï´Ù. ½ÉÀåÀÌ ¶Ù´Â µ¿¾È ÃøÁ¤ÀÌ ÀÌ·ç¾îÁö±â ¶§¹®¿¡ ½Ç½Ã°£ ¿µ»óÀ¸·Î ½ÉÀå ±â´ÉÀ» º¸´Ù Á¤È®ÇÏ°Ô Æò°¡ÇÒ ¼ö ÀÖ½À´Ï´Ù. ½ÉÀå ÇØºÎÇÐÀû ±¸Á¶ÀÇ °³¼±µÈ À̹ÌÁö¸¦ Á¦°øÇÏ´Â 3D ¿¡ÄÚ¸¦ ÅëÇØ ½ÉÀ庴 ȯÀÚ¿¡°Ô °¡Àå ÀûÇÕÇÑ Ä¡·á ¹æÄ§À» °áÁ¤ÇÒ ¼ö ÀÖ½À´Ï´Ù. Áö³ 20³âµ¿¾È ÄÄÇ»ÅÍ ¹× º¯È¯±â ±â¼úÀÇ ¹ßÀüÀ¸·Î 3D ½ÉÃÊÀ½ÆÄ °Ë»ç°¡ °³¹ßµÇ¾î ÀüÅëÀûÀÎ 2D ½ÉÃÊÀ½ÆÄ °Ë»ç¿¡ Áß¿äÇÑ ÀÓ»ó Á¤º¸¸¦ Ãß°¡ÇÏ¿© 2D ½ÉÃÊÀ½ÆÄ¿¡ ºñÇØ 3D ½ÉÃÊÀ½ÆÄ´Â ½ÉÀå ºÎÇÇ, ½É±Ù·®, ½ÉÀå ±â´ÉÀÇ Á¤·®È, ÆÇ¸· ±â´É Àå¾ÖÀÇ Ç¥½Ã ¹× Æò°¡ °³¼±, ¿µ»ó ȹµæ ½Ã°£ ´ÜÃà µî ¸¹Àº ÀÌÁ¡À» Á¦°øÇÕ´Ï´Ù. ¶ÇÇÑ º¹ÀâÇÑ ¸ð¾ç°ú ½ÉÀå ±¸Á¶ °£ÀÇ °ø°£Àû °ü°èÀÇ ½Ã°¢È¸¦ Çâ»ó½ÃÄÑ ½ÉÇ÷°ü ÃÊÀ½ÆÄ ½ÃÀå ¼ºÀå¿¡ ±àÁ¤ÀûÀÎ ¿µÇâÀ» ¹ÌĨ´Ï´Ù.
ÀûÀÀÁõ¿¡ ±â¹ÝÇÑ ÀλçÀÌÆ®
ÃÖÁ¾»ç¿ëÀÚº°·Î ½ÉÃÊÀ½ÆÄ ½ÃÀåÀº º´¿ø, ¿Ü·¡¼ö¼ú¼¾ÅÍ(ASC), Áø´Ü ½ÇÇè½Ç·Î ±¸ºÐµË´Ï´Ù. º´¿ø ºÎ¹®Àº 2022³â¿¡ °¡Àå Å« ½ÃÀå Á¡À¯À²À» Â÷ÁöÇϰí 2022-2030³â¿¡ °¡Àå ³ôÀº CAGRÀ» ³ªÅ¸³¾ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
¹Ì±¹ ½ÄǰÀǾ౹, ¼¼°èº¸°Ç±â±¸(WHO), ¹Ì±¹ Áúº´ÅëÁ¦¿¹¹æ¼¾ÅÍ(Centers for Disease Control and Prevention) µîÀº ½ÉÇ÷°ü ÃÊÀ½ÆÄ ½ÃÀå º¸°í¼¸¦ ÀÛ¼ºÇÒ ¶§ Âü°íÇÑ 1Â÷ ¹× 2Â÷ Á¤º¸ÀÔ´Ï´Ù.
¸ñÂ÷
Á¦1Àå ¼·Ð
Á¦2Àå ÁÖ¿ä ¿ä¾à
- ÁÖ¿ä ÀλçÀÌÆ®
- ½ÃÀåÀÇ ¸Å·Â ºÐ¼®
Á¦3Àå Á¶»ç ¹æ¹ý
Á¦4Àå ½ÉÇ÷°ü ÃÊÀ½ÆÄ ½ÃÀåÀÇ »óȲ
- PEST ºÐ¼®
- ÃÊÀ½ÆÄ ½Ã½ºÅÛ ºÐ¼®
Á¦5Àå ½ÉÇ÷°ü ÃÊÀ½ÆÄ ½ÃÀå : ÁÖ¿ä ½ÃÀå ¿ªÇÐ
- ÁÖ¿ä ½ÃÀå ÃËÁø¿äÀÎ
- ÁÖ¿ä ½ÃÀå ¾ïÁ¦¿äÀÎ
- ÁÖ¿ä ½ÃÀå ±âȸ
- ÇâÈÄ µ¿Çâ
- ÃËÁø¿äÀΰú ¾ïÁ¦¿äÀÎÀÇ ¿µÇ⠺м®
Á¦6Àå ½ÉÇ÷°ü ÃÊÀ½ÆÄ ½ÃÀå - ¼¼°è ½ÃÀå ºÐ¼®
- ½ÉÇ÷°ü ÃÊÀ½ÆÄ °Ë»ç - ¼¼°è ½ÃÀå °³¿ä
- ½ÉÇ÷°ü ÃÊÀ½ÆÄ °Ë»ç - ¼¼°è ½ÃÀå°ú ¿¹Ãø(-2031³â)
Á¦7Àå ½ÉÇ÷°ü ÃÊÀ½ÆÄ ½ÃÀå - ¸ÅÃ⠺м® - À¯Çüº°, 2021-2031³â
- °æÈ亮 ½ÉÃÊÀ½ÆÄ°Ë»ç
- °æ½Äµµ ½ÉÃÊÀ½ÆÄ°Ë»ç
- ½ºÆ®·¹½º ½ÉÃÊÀ½ÆÄ
- ÅÂ¾Æ ½ÉÃÊÀ½ÆÄ
Á¦8Àå ½ÉÇ÷°ü ÃÊÀ½ÆÄ ½ÃÀå - ¸ÅÃ⠺м® - ±â¼úº°, 2021-2031³â
- 2D ½ÉÃÊÀ½ÆÄ»çÁø
- 3D ½ÉÃÊÀ½ÆÄ»çÁø
- µµÇ÷¯
Á¦9Àå ½ÉÇ÷°ü ÃÊÀ½ÆÄ ½ÃÀå - ¸ÅÃ⠺м® - ÃÖÁ¾»ç¿ëÀÚº°, 2021-2031³â
- º´¿ø
- ¿Ü·¡ ¼ö¼ú ¼¾ÅÍ
- Áø´Ü ·¦
Á¦10Àå ½ÉÇ÷°ü ÃÊÀ½ÆÄ ½ÃÀå - ¸ÅÃ⠺м® - Áö¿ª ºÐ¼®,2021-2031³â
- ºÏ¹Ì
- À¯·´
- µ¶ÀÏ
- ÇÁ¶û½º
- ÀÌÅ»¸®¾Æ
- ½ºÆäÀÎ
- ¿µ±¹
- ±âŸ À¯·´
- ¾Æ½Ã¾ÆÅÂÆò¾ç
- È£ÁÖ
- Áß±¹
- Àεµ
- ÀϺ»
- Çѱ¹
- ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç
- Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
- ³²¾ÆÇÁ¸®Ä«°øÈ±¹
- »ç¿ìµð¾Æ¶óºñ¾Æ
- ¾Æ¶ø¿¡¹Ì¸®Æ®
- ±âŸ Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
- Áß³²¹Ì
- ºê¶óÁú
- ¾Æ¸£ÇîÆ¼³ª
- ±âŸ Áß³²¹Ì
Á¦11Àå ¾÷°è »óȲ
- ÇÕº´°ú Àμö
- °è¾à, Á¦ÈÞ, ÇÕº´»ç¾÷
- ½ÅÁ¦Ç° Ãâ½Ã
- »ç¾÷ È®´ë¿Í ±âŸ Àü·«Àû °³¹ß
Á¦12Àå °æÀï ±¸µµ
- ÁÖ¿ä ±â¾÷¿¡ ÀÇÇÑ È÷Æ®¸Ê ºÐ¼®
- ±â¾÷ÀÇ Æ÷Áö¼Å´×°ú ÁýÁßµµ
Á¦13Àå ½ÉÇ÷°ü ÃÊÀ½ÆÄ ½ÃÀå - ÁÖ¿ä ±â¾÷ °³¿ä
- Apex Heart and Vascular
- Ultra-X Imaging
- Metropolitan Heart Vascular Institute
- Ultromics Limited
- Corewell Health
- Centinela Hospital Medical Center
- Schoolcraft Memorial Hospital
- University of Utah Health
- Goshen Heart and Vascular Center
- Harefield Hospital
Á¦14Àå ºÎ·Ï
KSA
¿µ¹® ¸ñÂ÷
The cardiovascular echocardiography market size is expected to grow from US$ 143.72 billion in 2022 to US$ 200.00 billion by 2030; it is projected to register a CAGR of 4.2% during 2022-2030.
Cardiovascular echocardiography is a test that uses sound waves to create images of the heart. This testing procedure is usually performed on patients with suspected or known heart diseases. The test is painless and reveals the condition of the heart; the image shows the size, shape, chambers, and valves of the heart and their functioning. The cardiovascular echocardiogram can also identify parts of the heart that are not contracting properly. The injuries from the earlier heart attack can be clearly visualized using echocardiographs. The commonly used diagnostic test for detecting cardiac disorders is transthoracic cardiac ultrasound owing to its non-invasive nature. The cardiovascular echocardiography market growth is attributed to the rising burden of cardiovascular diseases and the advantages of echocardiographic devices over other cardiac diagnostic procedures. However, challenges associated with the use of echocardiography devices hinder the growth of the cardiovascular echocardiography market.
Type-Based Insights
Based on technology, the cardiovascular echocardiography market is categorized into 2D echocardiogram, 3D echocardiogram, and Doppler. The 3D echocardiogram segment held a significant cardiovascular echocardiography market share in 2022. The segment is estimated to register the highest CAGR during the forecast period. The 3D echocardiogram captures three-dimensional images of the heart structures and is used to improve image quality and reader confidence and assess structure and functionality. With measurements made while the heart is beating, the real-time images offer a more accurate evaluation of cardiac function. The best course of treatment for a patient with heart disease can be decided with the 3-D echo, which provides improved images of the heart's anatomy. Over the past two decades, advancements in computer and transducer technologies have allowed the development of 3D echocardiography, which provides significant additional clinical information to traditional 2D echocardiography. Compared to 2D echocardiography, 3D echocardiography offers numerous benefits, such as better quantitation of cardiac volumes, mass, and function, better display and assessment of valve dysfunction; and shorter image acquisition times. It also allows for improved visualization of complex shapes and spatial relations between cardiac structures, which positively influences the growth of the cardiovascular echocardiography market.
Indication-Based Insights
Based on end user, the cardiovascular echocardiography market is segmented into hospitals, ambulatory surgery centers, and diagnostic labs. The hospitals segment held a significant market share in 2022 and is expected to register the highest CAGR during 2022-2030.
The US Food and Drug Administration, the World Health Organization, and the Centers for Disease Control and Prevention are among the primary and secondary sources referred to while preparing the cardiovascular echocardiography market report.
Table Of Contents
1. Introduction
- 1.1 Scope of the Study
- 1.2 Market Definition, Assumptions and Limitations
- 1.3 Market Segmentation
2. Executive Summary
- 2.1 Key Insights
- 2.2 Market Attractiveness Analysis
3. Research Methodology
4. Cardiovascular Echocardiography Market Landscape
- 4.1 Overview
- 4.2 PEST Analysis
- 4.3 Ecosystem Analysis
- 4.3.1 List of Vendors in the Value Chain
5. Cardiovascular Echocardiography Market - Key Market Dynamics
- 5.1 Key Market Drivers
- 5.2 Key Market Restraints
- 5.3 Key Market Opportunities
- 5.4 Future Trends
- 5.5 Impact Analysis of Drivers and Restraints
6. Cardiovascular Echocardiography Market - Global Market Analysis
- 6.1 Cardiovascular Echocardiography - Global Market Overview
- 6.2 Cardiovascular Echocardiography - Global Market and Forecast to 2031
7. Cardiovascular Echocardiography Market - Revenue Analysis (USD Million) - By Type, 2021-2031
- 7.1 Overview
- 7.2 Transthoracic Echocardiography
- 7.3 Transesophageal Echocardiography
- 7.4 Stress Echocardiography
- 7.5 Fetal Echocardiography
8. Cardiovascular Echocardiography Market - Revenue Analysis (USD Million) - By Technology, 2021-2031
- 8.1 Overview
- 8.2 2D echocardiogram
- 8.3 3D echocardiogram
- 8.4 Doppler
9. Cardiovascular Echocardiography Market - Revenue Analysis (USD Million) - By End User, 2021-2031
- 9.1 Overview
- 9.2 Hospitals
- 9.3 Ambulatory Surgery Centers
- 9.4 Diagnostic Labs
10. Cardiovascular Echocardiography Market - Revenue Analysis (USD Million), 2021-2031 - Geographical Analysis
- 10.1 North America
- 10.1.1 North America Cardiovascular Echocardiography Market Overview
- 10.1.2 North America Cardiovascular Echocardiography Market Revenue and Forecasts to 2031
- 10.1.3 North America Cardiovascular Echocardiography Market Revenue and Forecasts and Analysis - By Type
- 10.1.4 North America Cardiovascular Echocardiography Market Revenue and Forecasts and Analysis - By Technology
- 10.1.5 North America Cardiovascular Echocardiography Market Revenue and Forecasts and Analysis - By End User
- 10.1.6 North America Cardiovascular Echocardiography Market Revenue and Forecasts and Analysis - By Countries
- 10.1.6.1 United States Cardiovascular Echocardiography Market
- 10.1.6.1.1 United States Cardiovascular Echocardiography Market, by Type
- 10.1.6.1.2 United States Cardiovascular Echocardiography Market, by Technology
- 10.1.6.1.3 United States Cardiovascular Echocardiography Market, by End User
- 10.1.6.2 Canada Cardiovascular Echocardiography Market
- 10.1.6.2.1 Canada Cardiovascular Echocardiography Market, by Type
- 10.1.6.2.2 Canada Cardiovascular Echocardiography Market, by Technology
- 10.1.6.2.3 Canada Cardiovascular Echocardiography Market, by End User
- 10.1.6.3 Mexico Cardiovascular Echocardiography Market
- 10.1.6.3.1 Mexico Cardiovascular Echocardiography Market, by Type
- 10.1.6.3.2 Mexico Cardiovascular Echocardiography Market, by Technology
- 10.1.6.3.3 Mexico Cardiovascular Echocardiography Market, by End User
Note - Similar analysis would be provided for below mentioned regions/countries
- 10.2 Europe
- 10.2.1 Germany
- 10.2.2 France
- 10.2.3 Italy
- 10.2.4 Spain
- 10.2.5 United Kingdom
- 10.2.6 Rest of Europe
- 10.3 Asia-Pacific
- 10.3.1 Australia
- 10.3.2 China
- 10.3.3 India
- 10.3.4 Japan
- 10.3.5 South Korea
- 10.3.6 Rest of Asia-Pacific
- 10.4 Middle East and Africa
- 10.4.1 South Africa
- 10.4.2 Saudi Arabia
- 10.4.3 U.A.E
- 10.4.4 Rest of Middle East and Africa
- 10.5 South and Central America
- 10.5.1 Brazil
- 10.5.2 Argentina
- 10.5.3 Rest of South and Central America
11. Industry Landscape
- 11.1 Mergers and Acquisitions
- 11.2 Agreements, Collaborations, Joint Ventures
- 11.3 New Product Launches
- 11.4 Expansions and Other Strategic Developments
12. Competitive Landscape
- 12.1 Heat Map Analysis by Key Players
- 12.2 Company Positioning and Concentration
13. Cardiovascular Echocardiography Market - Key Company Profiles
- 13.1 Apex Heart and Vascular
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments
Note - Similar information would be provided for below list of companies
- 13.2 Ultra-X Imaging
- 13.3 Metropolitan Heart Vascular Institute
- 13.4 Ultromics Limited
- 13.5 Corewell Health
- 13.6 Centinela Hospital Medical Center
- 13.7 Schoolcraft Memorial Hospital
- 13.8 University of Utah Health
- 13.9 Goshen Heart and Vascular Center
- 13.10 Harefield Hospital
14. Appendix
- 14.1 Glossary
- 14.2 About The Insight Partners
- 14.3 Market Intelligence Cloud
°ü·ÃÀÚ·á